The significance of IDH1 mutations in tumor-associated seizure in 60 Chinese patients with low-grade gliomas

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Liang, Ruofei ^a   Fan, Yingjun ^a   Wang, Xiang ^a   Mao, Qing ^a   Liu, Yanhui ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISOCITRATE DEHYDROGENASE 1; IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CHINESE; CONTROLLED STUDY; DIZZINESS; FEMALE; GENE MUTATION; GENERALIZED EPILEPSY; GLIOMA; HEADACHE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OLIGODENDROGLIOMA; PREDICTOR VARIABLE; RETROSPECTIVE STUDY; RISK FACTOR; SEIZURE; TONIC CLONIC SEIZURE; TUMOR ASSOCIATED SEIZURE; ASIAN; EPILEPSY; GENETICS; MUTATION; NONPARAMETRIC TEST; PATHOLOGY; RISK; STATISTICAL MODEL;

ASIAN CONTINENTAL ANCESTRY GROUP; EPILEPSY; GLIOMA; HUMANS; ISOCITRATE DEHYDROGENASE; LOGISTIC MODELS; MUTATION; ODDS RATIO; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84890040228     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/403942     Document Type: Article

References (27)

1. Lebrun C., Fontaine D., Bourg V., Ramaioli A., Chanalet S., Vandenbos F., Lonjon M., Fauchon F., Paquis P., Frenay M., Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy. European Journal of Neurology 2007 14 4 391 398 2-s2.0-33947604513 10.1111/j.1468-1331. 2007.01675.x (Pubitemid 46481159)
2. Lebrun C., Fontaine D., Ramaioli A., Vandenbos F., Chanalet S., Lonjon M., Michiels J. F., Bourg V., Paquis P., Chatel M., Frenay M., Long-term outcome of oligodendrogliomas. Neurology 2004 62 10 1783 1787 2-s2.0-2442653975 (Pubitemid 38661735)
3. Grabenbauer G. G., Roedel C. M., Paulus W., Ganslandt O., Schuchardt U., Buchfelder M., Schrell U., Fahlbusch R., Huk W. J., Sauer R., Supratentorial low-grade glioma: results and prognostic factors following postoperative radiotherapy. Strahlentherapie und Onkologie 2000 176 6 259 264 2-s2.0-0034125766 (Pubitemid 30407536)
4. You G., Sha Z.-Y., Yan W., Zhang W., Wang Y.-Z., Li S.-W., Sang L., Wang Z., Li G.-L., Li S.-W., Song Y.-J., Kang C.-S., Jiang T., Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. Neuro-Oncology 2012 14 2 230 241 2-s2.0-84859520953 10.1093/neuonc/nor205
5. DeAngelis L. M., Brain tumors. The New England Journal of Medicine 2001 344 2 114 123 2-s2.0-0035843243 10.1056/NEJM200101113440207 (Pubitemid 32052502)
6. Huang L., You G., Jiang T., Li G., Li S., Wang Z., Correlation between tumor-related seizures and molecular genetic profile in 103 Chinese patients with low-grade gliomas: a preliminary study. Journal of the Neurological Sciences 2011 302 1-2 63 67 2-s2.0-79951512390 10.1016/j.jns.2010.11.024
7. Brogna C., Robles S. G., Duffau H., Brain tumors and epilepsy. Expert Review of Neurotherapeutics 2008 8 6 941 955 2-s2.0-45749098839 10.1586/14737175.8.6.941 (Pubitemid 351872598)
8. Chang E. F., Potts M. B., Keles G. E., Lamborn K. R., Chang S. M., Barbaro N. M., Berger M. S., Seizure characteristics and control following resection in 332 patients with low-grade gliomas. Journal of Neurosurgery 2008 108 2 227 235 2-s2.0-38949200071 10.3171/JNS/2008/108/2/0227 (Pubitemid 351213284)
9. van Breemen M. S., Wilms E. B., Vecht C. J., Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. The Lancet Neurology 2007 6 5 421 430 2-s2.0-34047270232 10.1016/S1474-4422(07)70103-5 (Pubitemid 46551867)
10. Lee J. W., Wen P. Y., Hurwitz S., Black P., Kesari S., Drappatz J., Golby A. J., Wells W. M. III, Warfield S. K., Kikinis R., Bromfield E. B., Morphological characteristics of brain tumors causing seizures. Archives of Neurology 2010 67 3 336 342 2-s2.0-77749330734 10.1001/archneurol.2010.2
11. Lynam L. M., Lyons M. K., Drazkowski J. F., Sirven J. I., Noe K. H., Zimmerman R. S., Wilkens J. A., Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clinical Neurology and Neurosurgery 2007 109 7 634 638 2-s2.0-34347334657 10.1016/j.clineuro.2007.05. 017 (Pubitemid 47016762)
12. Chaichana K. L., Parker S. L., Olivi A., Quiñones-Hinojosa A., Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas: clinical article. Journal of Neurosurgery 2009 111 2 282 292 2-s2.0-68849132109 10.3171/2009.2.JNS081132
13. Yan H., Parsons D. W., Jin G., McLendon R., Rasheed B. A., Yuan W., Kos I., Batinic-Haberle I., Jones S., Riggins G. J., Friedman H., Friedman A., Reardon D., Herndon J., Kinzler K. W., Velculescu V. E., Vogelstein B., Bigner D. D., IDH1 and IDH2 mutations in gliomas. The New England Journal of Medicine 2009 360 8 765 773 2-s2.0-60849115270 10.1056/NEJMoa0808710
14. Watanabe T., Nobusawa S., Kleihues P., Ohgaki H., IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. American Journal of Pathology 2009 174 4 1149 1153 2-s2.0-65349150503 10.2353/ajpath.2009.080958
15. Balss J., Meyer J., Mueller W., Korshunov A., Hartmann C., von Deimling A., Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathologica 2008 116 6 597 602 2-s2.0-56749156414 10.1007/s00401-008-0455-2
16. Louis D. N., Ohgaki H., Wiestler O. D., Cavenee W. K., Burger P. C., Jouvet A., Scheithauer B. W., Kleihues P., The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica 2007 114 2 97 109 2-s2.0-34547122001 10.1007/s00401-007-0243-4 (Pubitemid 47103521)
17. Beaumont A., Whittle I. R., The pathogenesis of tumour associated epilepsy. Acta Neurochirurgica 2000 142 1 1 15 2-s2.0-0033972734 (Pubitemid 30068270)
18. Schaller B., Rüegg S. J., Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 2003 44 9 1223 1232 2-s2.0-0042415676 10.1046/j.1528-1157.2003.05203.x (Pubitemid 37100049)
19. Bordey A., Sontheimer H., Electrophysiological properties of human astrocytic tumor cells in situ: enigma of spiking glial cells. Journal of Neurophysiology 1998 79 5 2782 2793 2-s2.0-0031864971 (Pubitemid 28261657)
20. Bordey A., Sontheimer H., Properties of human glial cells associated with epileptic seizure foci. Epilepsy Research 1998 32 1-2 286 303 2-s2.0-0032169291 10.1016/S0920-1211(98)00059-X (Pubitemid 28419497)
21. Ye Z.-C., Sontheimer H., Glioma cells release excitotoxic concentrations of glutamate. Cancer Research 1999 59 17 4383 4391 2-s2.0-0033198997 (Pubitemid 29418758)
22. Ye Z.-C., Rothstein J. D., Sontheimer H., Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. Journal of Neuroscience 1999 19 24 10767 10777 2-s2.0-0033573392 (Pubitemid 30235723)
23. Ricci R., Bacci A., Tugnoli V., Battaglia S., Maffei M., Agati R., Leonardi M., Metabolic findings on 3T 1H-MR spectroscopy in peritumoral brain edema. American Journal of Neuroradiology 2007 28 7 1287 1291 2-s2.0-34548187175 10.3174/ajnr.A0564 (Pubitemid 47309660)
24. Dang L., White D. W., Gross S., Bennett B. D., Bittinger M. A., Driggers E. M., Fantin V. R., Jang H. G., Jin S., Keenan M. C., Marks K. M., Prins R. M., Ward P. S., Yen K. E., Liau L. M., Rabinowitz J. D., Cantley L. C., Thompson C. B., Vander Heiden M. G., Su S. M., Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009 462 7274 739 744 2-s2.0-72049125350 10.1038/nature08617
25. Kölker S., Pawlak V., Ahlemeyer B., Okun J. G., Hörster F., Mayatepek E., Krieglstein J., Hoffmann G. F., Köhr G., NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in D-2-hydroxyglutaric aciduria. European Journal of Neuroscience 2002 16 1 21 28 2-s2.0-0036458807 10.1046/j.1460-9568.2002.02055.x (Pubitemid 35463594)
26. Sahm F., Capper D., Pusch S., Balss J., Koch A., Langhans C.-D., Okun J. G., Von Deimling A., Detection of 2-hydroxyglutarate in formalin-fixed paraffin-embedded glioma specimens by gas chromatography/mass spectrometry. Brain Pathology 2012 22 1 26 31 2-s2.0-83555174898 10.1111/j.1750-3639.2011. 00506.x
27. Stockhammer F., Misch M., Helms H.-J., Lengler U., Prall F., Von Deimling A., Hartmann C., IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom. Seizure 2012 21 3 194 197 2-s2.0-84858082359 10.1016/j.seizure.2011.12.007